Dosing (225)Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity - Kratochwil, C; Apostolidis, L; Rathke, H; Apostolidis, C; Bicu, F; Bruchertseifer, F (Eur J Nucl Med Mol Imaging, 2021)
et al.